BlackRock Group’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$4.1M Buy
53,775
+4,230
+9% +$321K ﹤0.01% 1299
2016
Q3
$4.13M Sell
49,545
-7,189
-13% -$603K ﹤0.01% 1201
2016
Q2
$4.67M Sell
56,734
-2,304
-4% -$190K ﹤0.01% 1121
2016
Q1
$4.48M Sell
59,038
-254,902
-81% -$18.9M ﹤0.01% 1123
2015
Q4
$25.2M Sell
313,940
-398,739
-56% -$28.8M 0.01% 732
2015
Q3
$45.3M Buy
712,679
+5,680
+0.8% +$408K 0.03% 595
2015
Q2
$49.7M Buy
706,999
+62,556
+10% +$4.63M 0.03% 601
2015
Q1
$51.1M Buy
644,443
+81,496
+14% +$6.01M 0.03% 587
2014
Q4
$35.8M Buy
562,947
+67,111
+14% +$4.21M 0.02% 667
2014
Q3
$29.6M Buy
495,836
+77,650
+19% +$4.44M 0.02% 696
2014
Q2
$22.4M Sell
418,186
-12,939
-3% -$710K 0.01% 761
2014
Q1
$26M Buy
431,125
+402,931
+1,429% +$23.5M 0.02% 709
2013
Q4
$1.5M Sell
28,194
-311
-1% -$15.6K ﹤0.01% 1734
2013
Q3
$1.32M Buy
28,505
+2,158
+8% +$99K ﹤0.01% 1734
2013
Q2
$1.08M Buy
+26,347
New +$1.13M ﹤0.01% 1694

Other funds holding CRL